DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2  (02-2015)

Period of time： 2015年2期

Publisher： John Wiley & Sons Inc

Founded in： 1999

Total resources： 46

ISSN： 1462-8902

Subject： R Medicine and Health

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2

Menu

Diabetes, Obesity and Metabolism

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. i-i

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

What is the best approach to glycaemic control in patients with type 2 diabetes?

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 105-106

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Dipeptidyl peptidase‐4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 107-115

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Sevelamer in a diabetologist's perspective: a phosphate‐binding resin with glucose‐lowering potential

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 116-120

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Open flow microperfusion: pharmacokinetics of human insulin and insulin detemir in the interstitial fluid of subcutaneous adipose tissue

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 121-127

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Patient Empowerment Programme in primary care reduced all‐cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population‐based propensity‐matched cohort study

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 128-135

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double‐blind, active‐controlled, parallel group, multinational clinical trial

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 136-144

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Is insulin the most effective injectable antihyperglycaemic therapy?

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 145-151

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

A randomized, double‐blind, placebo‐controlled study on long‐term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: results of the Long‐Term ASP1941 Safety Evaluation in Patients with Type 2 Diabetes with Renal Impairment (LANTERN) study

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 152-160

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin‐induced insulin‐deficient diabetic mice by restoring brown adipose tissue function

DIABETES OBESITY & METABOLISM (ELECTRONIC),volume 17,issue 2 , Vol. 17, Iss. 2, 2015-02 , pp. 161-169

John Wiley & Sons Inc

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 17 item(s)